Genentech
CLL drug achieves ‘unprecedented’ remissions
December 9, 2013Research and Development, Sales and Marketing AbbVie, CML, Genentech, abt-199
AbbVie and Genentech’s investigational oncology drug ABT-199 has performed well in a Phase I trial for blood cancer, according to …
Google launches new health business
September 19, 2013Medical Communications, Sales and Marketing Apple, Genentech, Levinson, Roche, google
ImmTAC deal for Immunocore
June 27, 2013Research and Development, Sales and Marketing Genentech, ImmTAC, oxford biotech
Oxford-based biotech company Immunocore has signed what could be a $300 million deal with Genentech to discover and bring to …
Roche cuts 1,000 R&D jobs
June 27, 2012Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts
Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …
Genentech taken to task over Avastin production
May 15, 2012Manufacturing and Production Genentech, Phil Taylor, avastin, manufacturing
FDA inspections of a manufacturing facility for Roche/Genentech’s cancer drug Avastin (bevacizumab) uncovered a number of deficiencies which could increase …
Gilead buys manufacturing plant from Genentech
August 9, 2011Manufacturing and Production Genentech, Gilead, biologics
Roche unit Genentech has agreed to sell a clinical manufacturing plant in California to Gilead Sciences. The 70,000 sq. ft. …
Roche’s MabThera successor shows phase II promise
December 6, 2010Research and Development, Sales and Marketing GA101, Genentech, GlycArt, MabThera, Roche, blood cancer, chronic lymphocytic leukaemia
The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …
Pharma manufacturing news in brief
November 9, 2010Manufacturing and Production Genentech, Hovione, Jacobs Engineering, Laureate Pharma, Recipharm, contract manufacturing, pharma manufacturing
Hovione wins a patent dispute, Genentech is awarded for a manufacturing plant and there are new contracts for Recipharm, Jacobs …
Novartis’ Lucentis recommended for wider EU licence
October 25, 2010Sales and Marketing CHMP, Genentech, Lucentis, Novartis, diabetic macular edema, ranibizumab
Novartis’ Lucentis has been recommended for approval in Europe to treat people suffering from vison loss due to diabetes. The …
Genentech opens $400m fill-and-finish plant
April 8, 2010Manufacturing and Production Genentech
US biotech giant Genentech has officially opened its new 296,000 sq. ft. biologics manufacturing facility in Hillsboro, near Portland, Oregon. …
Genentech integration hits Roche profits
February 3, 2010Sales and Marketing 2009 financials, Genentech, Roche
Roche achieved healthy sales growth in 2009 but saw a 22% drop in net income due to the cost gaining …
Awards recognise top pharma manufacturing projects
January 19, 2010Manufacturing and Production Biogen, Genentech, Mannkind, Pfizer
The winners of the 2010 Facility of the Year Awards have been made public, with Pfizer grabbing two out of …
Roche lines up manufacturing and R&D reshuffle
April 1, 2009Sales and Marketing Genentech, Roche
Genentech's decision to succumb to Roche's $48.8 billion merger bid has signalled a revamp of manufacturing, R&D and other divisions …
Genentech urges shareholders to reject Roche bid
February 24, 2009Sales and Marketing Genentech, Roche
The battle for the future of Genentech has heated up after the company's board asked its shareholders to reject Roche's …
Biotech in 2008
December 31, 2008Research and Development Genentech, InClone, biotech, economy, investment
The credit crunch hits biotechBy October Europe's biotech sector was feeling severe effects from the credit crunch, with small and …
Latest content
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
